Cancer, Data and the Fallacy of the $1000 Genome
June 22, 2012
June 21, 2012 | In his first "Hacking Healthcare" blog, occasional Bio-IT World contributor Jim Golden discusses the central theme of a recent talk by Brigham & Women's Hospital pathologist Mark Boguski: "The time of the $1000 genome meme is over. It served us well for years – driving advances in instrumentation, chemistry and biology. But now it is reducing clinical credibility. It’s time for it to leave the lexicon of healthcare; it has to go." Forbes.com